0001181431-12-059306.txt : 20121119 0001181431-12-059306.hdr.sgml : 20121119 20121119140425 ACCESSION NUMBER: 0001181431-12-059306 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121115 FILED AS OF DATE: 20121119 DATE AS OF CHANGE: 20121119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 121214113 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 2696738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 4 1 rrd360858.xml PAPA FORM 4 11-15-2012 X0306 4 2012-11-15 0 0000820096 PERRIGO CO PRGO 0001242215 PAPA JOSEPH C C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN MI 49010 1 1 0 1 President and CEO Chairman Common Stock 2012-11-15 4 M 0 15000 30.06 A 130645 D Common Stock 2012-11-15 4 S 0 14200 100.7549 D 116445 D Common Stock 2012-11-15 4 S 0 800 101.2846 D 115645 D Employee Stock Option Right to Buy 30.06 2012-11-15 4 M 0 15000 0 D 2011-08-25 2019-08-25 Common Stock 17587 2587 D This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 29, 2011. This 10b5-1 sales plan will expire on the close of business November 20, 2012. The price in column 4 is a weighted average. The prices actually received ranged from $100.11 to $101.10. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $101.15 to $101.40. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Penny Bursma, Power of Attorney for Joseph C. Papa 2012-11-19